Document is current
Any future updates will be listed below
-
Authors
Wang, Joy Y. https://orcid.org/0000-0001-6646-4279
Pausch, Patrick https://orcid.org/0000-0001-8947-9107
Doudna, Jennifer A. https://orcid.org/0000-0001-9161-999X
- License Information
-
More Information
Article History
Accepted: 11 April 2022
First Online: 13 May 2022
Competing interests
: J.A.D. is a cofounder of Caribou Biosciences, Editas Medicine, Scribe Therapeutics, Intellia Therapeutics and Mammoth Biosciences. J.A.D. is a scientific advisory board member of Vertex, Caribou Biosciences, Intellia Therapeutics, Scribe Therapeutics, Mammoth Biosciences, Synthego, Algen Biotechnologies, Felix Biosciences, The Column Group and Inari. J.A.D. is the Chief Science Advisor of Sixth Street, is on the Board of Directors at Altos, Johnson & Johnson and Tempus, and has research projects sponsored by Biogen, Pfizer, AppleTree Partners and Roche. The Regents of the University of California have patents issued and pending for CRISPR technologies on which P.P. and J.A.D. are named as inventors. J.Y.W. declares no competing interests.
